Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy

Summary

New England Journal of Medicine published a study comparing obinutuzumab and tacrolimus for treating primary membranous nephropathy. The article represents a routine clinical research publication without specifics on trial outcomes or regulatory implications.